Members of the Pan UK Pharmacy Working Group for ATMPs have collaborated with UK BMT (Bone Marrow Transplant) pharmacists to produce a CAR-T training passport
A summary of the implications of the UKs exit from the EU for clinical trial sites for both IMP and ATIMPs, including supply to and from Northern Ireland
This document provides expert clinical pharmacy guidance on supportive medicines in order to facilitate the treatment of complex CAR-T Cell Therapy patients.
This guidance provides advice for ATMP developers, highlighting implementation challenges faced by the NHS and suggesting design consideration to minimise them.